Reforming the Medicare Part D benefit design: Financial implications for beneficiaries, private plans, drug manufacturers, and the federal government Erin Trish, Katrina Kaiser, Jeanai Celestin, and Geoffrey Joyce Wednesday, January 11, 2023
